Journal profile · CRITICAL CARE MEDICINE
Medicina Intensiva
ISSN 0210-5691 · eISSN 1578-6749 · Ediciones Doyma, S.L. · SPAIN
Medicina Intensiva: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 2.31; hybrid open access; APC about USD 2,640; review about 62 days (submission to acceptance, publisher); community-reported acceptance: easy; 180 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Medicina Intensiva is published by Ediciones Doyma, S.L. and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Respiratory Support and Mechanisms, Sepsis Diagnosis and Treatment and Cardiac Arrest and Resuscitation, together about 29.2% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
Medicina Intensiva is the journal of the Spanish Society of Intensive Care Medicine and Coronary Units (SEMICYUC) and of Pan American and Iberian Federation of Societies of Intensive and Critical Care Medicine. Medicina Intensiva has become the reference publication in Spanish in its field. The journal mainly publishes Original Articles, Reviews, Clinical Notes, Consensus Documents, Images, and other information relevant to the specialty. All works go through a rigorous selection process. The journal accepts submissions of articles in English and in Spanish languages. The journal follows the publication requirements of the International Committee of Medical Journal Editors (ICMJE) and the Committee on Publication Ethics (COPE).Medicina Intensiva es la revista de la Sociedad Española de Medicina Intensiva, Crítica y Unidades Coronarias (SEMICYUC) y de la Federación Panamericana e Ibérica de Sociedades de Medicina Crítica y Terapia Intensiva. Medicina Intensiva se ha convertido en la publicación de referencia en castellano de la especialidad. La revista publica principalmente artículos Originales, Revisiones, Artículos de consenso, Imágenes en Medicina Intensiva e Información relevante de la especialidad. La revista acepta artículos escritos en español o en inglés. Medicina Intensiva sigue las normas de publicación del Comité Internacional de Editores de Revistas Médicas (ICMJE) y del Comité sobre Publicación Ética (COPE).
From the journal's Aims & Scope
Research area (LetPub): CRITICAL CARE MEDICINE
Editor-in-chief Federico GordoPublisher website
Editorial board by country: none in mainland China; most named Spain 8, Mexico 3 (11 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Respiratory Support and MechanismsMedicine11%
- Sepsis Diagnosis and TreatmentMedicine10.2%
- Cardiac Arrest and ResuscitationMedicine8%
- Intensive Care Unit Cognitive DisordersMedicine8%
- Nosocomial Infections in ICUMedicine6.2%
- Medical research and treatmentsMedicine4.8%
- Nursing care and researchHealth Professions4.5%
- Cardiac, Anesthesia and Surgical OutcomesMedicine4.4%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Critical Care Medicine | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Critical Care Medicine | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Critical Care Medicine | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
PubMedPublisher website
Other: Crossref
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 2.31LetPub ·
- Impact factor (publisher)
- 2.5Publisher website ·
- Impact factor (publisher) 2024
- 2.5Publisher website ·
- CiteScore 2026-06
- 2.2LetPub ·
- CiteScore (publisher)
- 2.2Publisher website ·
- CiteScore (publisher) 2024
- 2.2Publisher website ·
- SJR 2026-06
- 0.35LetPub ·
- SNIP 2026-06
- 0.62LetPub ·
- h-index
- 24LetPub ·
- h-index
- 51OpenAlex ·
- i10-index
- 683OpenAlex ·
- 2-year mean citedness
- 0.54OpenAlex ·
- Self-citation rate
- 20%LetPub ·
- Share of gold OA articles
- 11.56%LetPub ·
Volume
- Articles per year
- 61LetPub ·
Articles by year OpenAlex count · 4,198 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 669 | 84 | 19 |
| 2025 | 180 | 19 | 150 |
| 2024 | 182 | 18 | 384 |
| 2023 | 119 | 17 | 266 |
| 2022 | 103 | 28 | 449 |
| 2021 | 135 | 58 | 640 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Publisher-reported review time from the journal's website
62 dayssubmission to acceptance · community reports 6–12 weeks
The publisher's own definition applies; dates from this journal's articles in the last 24 months are not available yet, so the publisher's figure is used.
Figures by source
- Average review time (community reports)
- 6–12 weeksLetPub ·
- Average acceptance (community reports)
- EasyLetPub ·
- Submission to first decision
- 16 daysPublisher website ·
- First decision after review
- 39 daysPublisher website ·
- Submission to acceptance
- 62 daysPublisher website ·
- Peer review
- Double anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 2,640 / EUR 2,410 / GBP 2,110 / JPY 327,440 | — | — | |
| Publisher website | USD 2,640 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare5 items from the author guidelines
- Abstract
- ≤ 250 words
- Keywords
- 3–10
- Manuscript length
- ≤ 3,000 words
- Reference style
- Vancouver
- Cover letter
- Required
Article types accepted18
- editorialThe MEDICINA INTENSIVA journal is comprised of the following sections: Original Articles.This category includes randomised clinical trials, cohort studies, stud…Length not stated
- editorialsEditorials.Included in this section are works in which the author/s discuss and analyse an Original published in the Journal.Length not stated
- images in intensive medicineImages in Intensive Medicine.This section will publish all types of images that are demonstrative and contain a teaching message by themselves.Length not stated
- letterScientific letters.A description of several clinical cases in which are described new aspects or important added value on the pathophysiology of the disease, it…Length not stated
- letter to the editorScientific letters.A description of several clinical cases in which are described new aspects or important added value on the pathophysiology of the disease, it…Length not stated
- letters to the editorScientific letters.A description of several clinical cases in which are described new aspects or important added value on the pathophysiology of the disease, it…Length not stated
- meta-analysisThe MEDICINA INTENSIVA journal is comprised of the following sections: Original Articles.This category includes randomised clinical trials, cohort studies, stud…Length not stated
- opinionUpdates. Reviews commissioned by the Editorial Committee of MEDICINA INTENSIVA are included in this section and will be part of a series that will review in det…Length not stated
- original articleThe MEDICINA INTENSIVA journal is comprised of the following sections: Original Articles.This category includes randomised clinical trials, cohort studies, stud…Length not stated
- original articlesOriginal Articles.This category includes randomised clinical trials, cohort studies, studies on screening or diagnostic tests, cost-effective analyses, meta-ana…Length not stated
- points of viewPoints of View. The articles included in this section are those in which an opinion is expressed about a controversial topic in the field of intensive care medi…Length not stated
- reviewThe MEDICINA INTENSIVA journal is comprised of the following sections: Original Articles.This category includes randomised clinical trials, cohort studies, stud…Length not stated
- review articleThe MEDICINA INTENSIVA journal is comprised of the following sections: Original Articles.This category includes randomised clinical trials, cohort studies, stud…Length not stated
- review articlesReview Articles. These articles present updates on a specific topic in the field of intensive care medicine.Length not stated
- scientific lettersScientific letters.A description of several clinical cases in which are described new aspects or important added value on the pathophysiology of the disease, it…Length not stated
- special articlesSpecial Articles. This section includes articles written by scientific societies, workgroups or groups of experts (clinical practice guidelines, consensus confe…Length not stated
- systematic reviewThe MEDICINA INTENSIVA journal is comprised of the following sections: Original Articles.This category includes randomised clinical trials, cohort studies, stud…Length not stated
- updatesUpdates. Reviews commissioned by the Editorial Committee of MEDICINA INTENSIVA are included in this section and will be part of a series that will review in det…Length not stated
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, Publication ethics, License & copyright, Open access, Peer review, Preprints
- AI use Declaration of generative AI in scientific writing
Authors must declare the use of generative AI tools in the manuscript preparation process upon submission of the paper.Generative AI and AI-assisted technologies (“AI tools”) have been rapidly adopted in research and scholarly publishing, offering significant benefits while requiring clear standards for responsible and transparent use.Authors preparing a manuscript for this journal may use AI tool…
Source ↗Publisher website ·- Authorship Authorship
All authors should have made substantial contributions to all of the following: (1) the conception and design of the study, or acquisition of data, or analysis and interpretation of data, (2) drafting the article or revising it critically for important intellectual content, (3) final approval of the version to be submitted.ContributorsEach author is required to declare his or her individual contri…
Source ↗Publisher website ·- Conflicts of interest Declaration of interest
All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence (bias) their work. Examples of potential competing interests include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/registrations, and grants or other funding. Authors must disclose any interests in two places:…
Source ↗Publisher website ·- Publication ethics
ICMJE compliance Model summary
MEDICINA INTENSIVA complies with the guidelines of the International Committee of Medical Journal Editors: Uniform requirements for manuscripts submitted to biomedical journals.
Source ↗Publisher website ·- License & copyright Copyright
Upon acceptance of an article, authors will be asked to complete a 'Journal Publishing Agreement' (see more information on this). An e-mail will be sent to the corresponding author confirming receipt of the manuscript together with a 'Journal Publishing Agreement' form or a link to the online version of this agreement.Subscribers may reproduce tables of contents or prepare lists of articles includ…
Source ↗Publisher website ·- Open access Open access
Please visit our Open Access page for more information about open access publishing in this journal.
Source ↗Publisher website ·- Peer review Peer review
Double anonymized peer review Model summary
This journal operates a double anonymized review process. All contributions will be initially assessed by the editor for suitability for the journal. Papers deemed suitable are then typically sent to a minimum of two independent expert reviewers to assess the scientific quality of the paper. The Editor is responsible for the final decision regarding acceptance or rejection of articles. The Editor'…
Source ↗Publisher website ·- Preprints Preprints
Preprint sharing allowed Model summary
Please note that preprints can be shared anywhere at any time, in line with Elsevier's sharing policy. Sharing your preprints e.g. on a preprint server will not count as prior publication (see 'Multiple, redundant or concurrent publication' for more information).
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Ediciones Doyma, S.L.
- Country or region
- SPAIN
- Language
- Multi-Language
- ISSN
- 0210-5691
- Electronic ISSN
- 1578-6749
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Medicina Intensiva
What CAS zone is Medicina Intensiva in?
In the 2025 upgraded edition of the CAS Journal Ranking, Medicina Intensiva is in Zone 4 of Medicine, and in Zone 4 of the minor category Critical Care Medicine. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Medicina Intensiva?
The latest impact factor listed by LetPub is 2.31; CiteScore 2.2, h-index 51.
How long does peer review take at Medicina Intensiva?
The publisher reports about 62 days (submission to acceptance); authors report an average review time of 6–12 weeks; the community-reported acceptance is “Easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Medicina Intensiva?
According to the journal's author guidelines: Abstract: ≤ 250 words; Keywords: 3–10; Manuscript length: ≤ 3,000 words; Reference style: Vancouver; Cover letter: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Medicina Intensiva based?
Of the 11 board members whose country the journal's board page names, none are in mainland China; the countries named most often are Spain (8) and Mexico (3). Counted from the institutions listed on the board page; for reference only.
Which databases index Medicina Intensiva?
According to LetPub and DOAJ records, Medicina Intensiva is indexed in SCIE and Scopus. The journal's website also lists PubMed; that list has not been checked against each database.
Is Medicina Intensiva open access, and what is the APC?
Medicina Intensiva is a hybrid journal. For open-access publication: APC about USD 2,640.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .